Ieq Capital, LLC Biogen Inc. Transaction History

Ieq Capital, LLC

$7.35 Billion
Q2 2024

A detailed history of Ieq Capital, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 3,742 shares of BIIB stock, worth $732,047. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,742

Previous 3,133 19.44%

Holding current value

$732,047

Previous $675,000 28.44%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $116,026 - $144,162	609 Added 19.44%	3,742 $867,000
Q1 2024 May 08, 2024	SELL	$212.02 - $267.71 $243,823 - $307,866	-1,150 Reduced 26.85%	3,133 $675,000
Q4 2023 Feb 07, 2024	SELL	$222.59 - $267.94 $148,912 - $179,251	-669 Reduced 13.51%	4,283 $1.11 Million
Q3 2023 Nov 03, 2023	BUY	$253.3 - $285.89 $209,479 - $236,431	827 Added 20.05%	4,952 $1.27 Million
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $117,256 - $135,493	426 Added 11.52%	4,125 $1.18 Million
Q1 2023 May 01, 2023	BUY	$256.56 - $292.34 $32,583 - $37,127	127 Added 3.56%	3,699 $1.03 Million
Q4 2022 Feb 03, 2023	BUY	$252.44 - $306.72 $70,178 - $85,268	278 Added 8.44%	3,572 $989,000
Q3 2022 Nov 03, 2022	BUY	$194.69 - $268.46 $204,619 - $282,151	1,051 Added 46.86%	3,294 $879,000
Q2 2022 Jul 27, 2022	BUY	$187.54 - $223.02 $134,653 - $160,128	718 Added 47.08%	2,243 $457,000
Q1 2022 Apr 26, 2022	BUY	$193.77 - $244.14 $101,147 - $127,441	522 Added 52.04%	1,525 $321,000
Q4 2021 Jan 31, 2022	SELL	$223.92 - $287.77 $245,640 - $315,683	-1,097 Reduced 52.24%	1,003 $241,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $145,456 - $189,691	514 Added 32.41%	2,100 $593,000
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $88,837 - $142,245	343 Added 27.59%	1,586 $549,000
Q1 2021 May 04, 2021	BUY	$242.95 - $284.63 $301,986 - $353,795	1,243 New	1,243 $348,000
Q4 2020 Feb 03, 2021	SELL	$236.26 - $355.63 $244,529 - $368,077	-1,035 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $274,036 - $316,409	1,035 New	1,035 $294,000
Q2 2020 Jul 31, 2020	SELL	$258.66 - $342.55 $398,336 - $527,527	-1,540 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$268.85 - $341.04 $135,769 - $172,225	505 Added 48.79%	1,540 $488,000
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $61,616 - $85,139	-280 Reduced 21.29%	1,035 $308,000
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $289,378 - $399,852	1,315 New	1,315 $247,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account